Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> INNOCARE PHARMA (09969.HK) Achieves RMB642 Million Net Profit for Full Year, Turns Loss into Profit
Recommend 0 Positive 1 Negative 0 |
||||
|
||||
|
INNOCARE PHARMA (09969.HK) announced its 2025 annual results, reporting revenue of RMB2.375 billion, representing a year-on-year increase of 135.3%. The company recorded a net profit of RMB642 million, compared to a loss of RMB441 million in the previous year, turning from loss to profit; earnings per share were RMB0.38. No final dividend was declared. (de/d) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
